{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:36:16Z","timestamp":1789731376397,"version":"4.0.1"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0141921","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T19:09:33Z","timestamp":1446664173000},"page":"e0141921","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":32,"title":["Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats"],"prefix":"10.1371","volume":"10","author":[{"given":"Shunsuke","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Ushio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Masuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryozo","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"issue":"Suppl 1","key":"ref1","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.3816\/CCC.2005.s.006","article-title":"Clinical management of oxaliplatin-associated neurotoxicity","volume":"5","author":"A Grothey","year":"2005","journal-title":"Clin Colorectal Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1200\/JCO.2002.07.056","article-title":"Acute oxaliplatin-induced peripheral nerve hyperexcitability","volume":"20","author":"RH Wilson","year":"2002","journal-title":"J Clin Oncol"},{"key":"ref3","first-page":"263","article-title":"Oxaliplatin, an anticancer agent that affects both Na<sup>+<\/sup> and K<sup>+<\/sup> channels in frog peripheral myelinated axons","volume":"25","author":"E Benoit","year":"2006","journal-title":"Gen Physiol Biophys"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuro.2008.09.005","article-title":"The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat","volume":"29","author":"A Kagiava","year":"2008","journal-title":"Neurotoxicology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1744-8069-8-7","article-title":"L type Ca\u00b2<sup>+<\/sup> channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats","volume":"8","author":"T Kawashiri","year":"2012","journal-title":"Mol Pain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1744-8069-8-55","article-title":"Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice","volume":"8","author":"M Zhao","year":"2012","journal-title":"Mol Pain"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.celrep.2015.04.027","article-title":"The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia","volume":"11","author":"S Lolignier","year":"2015","journal-title":"Cell Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2006.01.001","article-title":"Oxaliplatin-related neurotoxicity: how and why?","volume":"59","author":"LM Pasetto","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref9","first-page":"249","article-title":"Management of oxaliplatin-induced peripheral neuropathy","volume":"1","author":"MW Saif","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2006.08.6652","article-title":"Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07","volume":"25","author":"SR Land","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat","volume":"37","author":"G Cavaletti","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuro.2009.01.003","article-title":"Role of MAPKs in platinum-induced neuronal apoptosis","volume":"30","author":"A Scuteri","year":"2009","journal-title":"Neurotoxicology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuro.2006.04.010","article-title":"Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding","volume":"27","author":"LE Ta","year":"2006","journal-title":"Neurotoxicology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00280-004-0953-4","article-title":"Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell loss","volume":"56","author":"SM Jamieson","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jpain.2012.11.002","article-title":"Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"14","author":"SY Yoon","year":"2013","journal-title":"J Pain"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.expneurol.2014.06.016","article-title":"Glial role in oxaliplatin-induced neuropathic pain","volume":"261","author":"L Di Cesare Mannelli","year":"2014","journal-title":"Exp Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.neuroscience.2014.05.051","article-title":"Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat","volume":"274","author":"CR Robinson","year":"2014","journal-title":"Neuroscience"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e0128080","DOI":"10.1371\/journal.pone.0128080","article-title":"Antineuropathic profile of <italic>N<\/italic>-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity","volume":"10","author":"L Di Cesare Mannelli","year":"2015","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuropharm.2013.10.034","article-title":"Involvement of \u03b17 nAChR subtype in rat oxaliplatin-induced neuropathy: effects of selective activation","volume":"79","author":"L Di Cesare Mannelli","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref20","first-page":"1205","article-title":"Clinical pharmacokinetics of oxaliplatin: a critical review","volume":"6","author":"MA Graham","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejpain.2010.08.006","article-title":"Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model","volume":"15","author":"T Kawashiri","year":"2011","journal-title":"Eur J Pain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"Oxaiplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"M Sakurai","year":"2009","journal-title":"Pain"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1744-8069-7-8","article-title":"Involvement of spinal NR2B-containing NMDA receptors in oxaliplatin-induced mechanical allodynia in rats","volume":"7","author":"Y Mihara","year":"2011","journal-title":"Mol Pain"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-8069-8-26","article-title":"Inhibition of Ca<sup>2+<\/sup>\/calmodulin-dependent protein kinase II reverses oxaliplatin-induced mechanical allodynia in rats","volume":"8","author":"M Shirahama","year":"2012","journal-title":"Mol Pain"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neures.2014.02.004","article-title":"Oxaliplatin induces hypomyelination and reduced neuregulin 1 expression in the rat sciatic nerve","volume":"80","author":"K Tsutsumi","year":"2014","journal-title":"Neurosci Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline","volume":"32","author":"DL Hershman","year":"2014","journal-title":"J Clin Oncol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2337\/db10-1462","article-title":"Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice","volume":"60","author":"T Himeno","year":"2011","journal-title":"Diabetes"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/NEN.0b013e3182580673","article-title":"Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy","volume":"71","author":"M Kan","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1111\/j.1476-5381.2011.01272.x","article-title":"Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats","volume":"164","author":"WJ Liu","year":"2011","journal-title":"Br J Pharmacol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"315848","DOI":"10.1155\/2013\/315848","article-title":"Therapeutic effect of exendin-4, a long-acting analogue of glucagon-like peptide-1 receptor agonist, on nerve regeneration after the crush nerve injury","volume":"2013","author":"K Yamamoto","year":"2013","journal-title":"Biomed Res Int"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"T Perry","year":"2007","journal-title":"Exp Neurol"},{"key":"ref32","first-page":"4837","article-title":"Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway","volume":"8","author":"H Li","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"MJ During","year":"2003","journal-title":"Nat Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Y Li","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1096\/fj.09-133454","article-title":"Ciliary neurotrophic factor recruitment of glucagon-like peptide-1 mediates neurogenesis, allowing immortalization of adult murine hypothalamic neurons","volume":"23","author":"DD Belsham","year":"2009","journal-title":"FASEB J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"M Zimmermann","year":"1983","journal-title":"Pain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e82016","DOI":"10.1371\/journal.pone.0082016","article-title":"Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats","volume":"8","author":"K Eakin","year":"2013","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2011-1795","article-title":"Glucagon-like peptide-1 receptor agonist, exendin-4, regulates feeding-associated neuropeptides in hypothalamic neurons in vivo and in vitro","volume":"153","author":"PS Dalvi","year":"2012","journal-title":"Endocrinology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.peptides.2012.06.006","article-title":"Protection of exenatide for retinal ganglion cells with different glucose concentrations","volume":"37","author":"Z Fu","year":"2012","journal-title":"Peptides"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ejca.2011.08.009","article-title":"Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents","volume":"48","author":"S Ushio","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1007\/s11357-012-9464-0","article-title":"Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice","volume":"35","author":"L Rachmany","year":"2013","journal-title":"Age (Dordr)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00418-015-1333-3","article-title":"Neurotrophic and neuroprotective properties of exendin-4 in adult rat dorsal root ganglion neurons: involvement of insulin and RhoA","volume":"144","author":"M Tsukamoto","year":"2015","journal-title":"Histochem Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"S Teramoto","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/jnc.12036","article-title":"Neuroprotective actions of glucagon-like peptide-1 in differentiated human neuroprogenitor cells","volume":"123","author":"K Velmurugan","year":"2012","journal-title":"J Neurochem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-130584","article-title":"The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice","volume":"37","author":"H Xiong","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1124\/jpet.300.3.958","article-title":"A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells","volume":"300","author":"T Perry","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2010.09.028","article-title":"NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK\/Sapk and ERK1\/2","volume":"486","author":"A Scuteri","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1523\/JNEUROSCI.4703-13.2014","article-title":"Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity","volume":"34","author":"N Gong","year":"2014","journal-title":"J Neurosci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1677\/JOE-09-0132","article-title":"Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson&apos;s disease","volume":"202","author":"S Kim","year":"2009","journal-title":"J Endocrinol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/annonc\/mdp509","article-title":"Incidence and evolution of oxaliplatin-induced peripheral sensory neuropathy in diabetic patients with colorectal cancer: a pooled analysis of three phase III studies","volume":"21","author":"RK Ramanathan","year":"2010","journal-title":"Ann Oncol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00520-012-1667-5","article-title":"Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV","volume":"21","author":"B Vincenzi","year":"2013","journal-title":"Support Care Cancer"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0141921","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T07:52:16Z","timestamp":1567324336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0141921"}},"subtitle":[],"editor":[{"given":"Christian","family":"Holscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0141921","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}